These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4571145)

  • 21. Clinical and pharmacokinetic factors affecting response to phenelzine.
    Tyrer P; Gardner M; Lambourn J; Whitford M
    Br J Psychiatry; 1980 Apr; 136():359-65. PubMed ID: 6992903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Issues in the design of trials for the evaluation of psychopharmacological treatments for social phobia.
    Liebowitz MR; Heimberg RG
    Int Clin Psychopharmacol; 1996 Jun; 11 Suppl 3():49-53. PubMed ID: 8923110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive -anxiety states. A controlled clinical trial.
    Robinson DS; Nies A; Ravaris CL; Lamborn KR
    Arch Gen Psychiatry; 1973 Sep; 29(3):407-13. PubMed ID: 4579506
    [No Abstract]   [Full Text] [Related]  

  • 24. Phenelzine and sexuality.
    Warneke L
    J Clin Psychiatry; 1994 May; 55(5):216-7. PubMed ID: 8071274
    [No Abstract]   [Full Text] [Related]  

  • 25. Cognitive behavioral group therapy vs phenelzine therapy for social phobia: 12-week outcome.
    Heimberg RG; Liebowitz MR; Hope DA; Schneier FR; Holt CS; Welkowitz LA; Juster HR; Campeas R; Bruch MA; Cloitre M; Fallon B; Klein DF
    Arch Gen Psychiatry; 1998 Dec; 55(12):1133-41. PubMed ID: 9862558
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of stuttering with phenelzine.
    Oberlander E; Schneier F; Liebowitz MR
    Am J Psychiatry; 1993 Feb; 150(2):355-6. PubMed ID: 8422103
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical pharmacology of phenelzine.
    Robinson DS; Nies A; Ravaris CL; Ives JO; Bartlett D
    Arch Gen Psychiatry; 1978 May; 35(5):629-35. PubMed ID: 365127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoamine oxidase inhibitors in obsessive-compulsive disorder.
    Jenike MA; Surman OS; Cassem NH; Zusky P; Anderson WH
    J Clin Psychiatry; 1983 Apr; 44(4):131-2. PubMed ID: 6833198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response to phenelzine and amitriptyline in subtypes of outpatient depression.
    Paykel ES; Rowan PR; Parker RR; Bhat AV
    Arch Gen Psychiatry; 1982 Sep; 39(9):1041-9. PubMed ID: 7052009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenelzine for chronic depression: a study of continuation treatment.
    Harrison W; Rabkin J; Stewart JW; McGrath PJ; Tricamo E; Quitkin F
    J Clin Psychiatry; 1986 Jul; 47(7):346-9. PubMed ID: 3522558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive-behavioral and pharmacological treatments of social phobia. A controlled study.
    Gelernter CS; Uhde TW; Cimbolic P; Arnkoff DB; Vittone BJ; Tancer ME; Bartko JJ
    Arch Gen Psychiatry; 1991 Oct; 48(10):938-45. PubMed ID: 1929764
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case of social phobia with avoidant personality disorder treated with MAOI.
    Deltito JA; Perugi G
    Compr Psychiatry; 1986; 27(3):255-8. PubMed ID: 3709141
    [No Abstract]   [Full Text] [Related]  

  • 33. Acetylator status and response to phenelzine in depressed patients.
    Johnstone EC; Marsh W
    Lancet; 1973 Mar; 1(7803):567-70. PubMed ID: 4120641
    [No Abstract]   [Full Text] [Related]  

  • 34. [Phenelzin in agoraphobia].
    Lerner J
    Harefuah; 1974 Nov; 87(10):463. PubMed ID: 4435606
    [No Abstract]   [Full Text] [Related]  

  • 35. Physical disability and social phobia.
    Oberlander EL; Schneier FR; Liebowitz MR
    J Clin Psychopharmacol; 1994 Apr; 14(2):136-43. PubMed ID: 8195455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current concepts in psychiatry. Panic attacks and phobias.
    Sheehan DV
    N Engl J Med; 1982 Jul; 307(3):156-8. PubMed ID: 7045660
    [No Abstract]   [Full Text] [Related]  

  • 37. A guide for drug use in depressive disorders.
    Raskin A
    Am J Psychiatry; 1974 Feb; 131(2):181-5. PubMed ID: 4358190
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.
    Sheehan DV; Ballenger J; Jacobsen G
    Arch Gen Psychiatry; 1980 Jan; 37(1):51-9. PubMed ID: 7352840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive-behavioral therapy for social anxiety disorder: model, methods, and outcome.
    Otto MW
    J Clin Psychiatry; 1999; 60 Suppl 9():14-9. PubMed ID: 10335675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenelzine treatment of elective mutism: a case report.
    Golwyn DH; Weinstock RC
    J Clin Psychiatry; 1990 Sep; 51(9):384-5. PubMed ID: 2211551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.